Eva Live Inc. filings document material events for an AI-driven digital advertising and marketing technology company. The company’s Form 8-K reports cover product announcements for Eva Brain, NeuroServer, and Fast Quote Direct; Nasdaq listing disclosures; and press-release exhibits describing campaign management, ad-serving, lead-generation, and automation initiatives.
The filing record also includes capital-structure and financing disclosures, including an equity distribution agreement for common stock, a secured convertible note, shelf registration and prospectus-supplement references, and related legal opinions. These disclosures frame GOAI’s public-company reporting around operating results, securities offerings, governance matters, and the funding of its AI advertising platform expansion.
Eva Live Inc (GOAI) director Aspin Philip John filed an initial statement of beneficial ownership, reporting direct holdings of 151,250 shares of Common Stock, par value $0.0001 per share. The filing lists this position as a holding entry, with no reportable purchase, sale, or derivative transaction.
Eva Live Inc (GOAI) disclosed that director Daryl Richard Walser has filed an initial statement of beneficial ownership on Form 3. The filing reports that he directly owns 123,750 shares of the company’s Common Stock, par value $0.0001 per share.
Eva Live Inc (GOAI) filed an initial statement of beneficial ownership reporting that Shadman Ali is a director of the company. The filing lists no reportable holdings of Eva Live Inc securities and shows no purchases, sales, grants, or other equity transactions at this time.
Eva Live Inc (GOAI) disclosed the initial insider holdings of its Chief Executive Officer and director, David Boulette, in a Form 3. As of January 27, 2026, Boulette is reported as a ten percent owner, holding 19,025,000 shares of Eva Live Inc common stock directly.
Eva Live Inc (symbol: GOAI) is the issuer of record for a Form DEF 14C filing submitted to the SEC.
Eva Live Inc (symbol: GOAI) is the issuer of record for a Form 8-K filing submitted to the SEC.
Eva Live Inc. (GOAI) discloses that its board and controlling stockholder, David Boulette, who holds 58.12% of the voting power, have approved by written consent three major actions: a full amendment and restatement of the articles of incorporation, adoption of a new 2026 Equity Incentive Plan reserving 2,000,000 common shares, and a large performance-based stock award for the CEO in the form of Series A Convertible Preferred Stock.
The new articles keep authorized capital at 300,000,000 common and 5,000,000 preferred shares but add anti-takeover features (Nevada Control Share and Business Combination statutes), limit bylaw changes to the board, require cause and a supermajority to remove directors, and adopt a Nevada exclusive-forum clause. The CEO’s new five‑year employment agreement sets a base salary of $800,000 with 10% annual increases, potential issuance of up to 1,000,000 Series A Preferred shares (each convertible into 150 common shares) tied to sales and strategic milestones, and a $5,000,000 severance if terminated without cause or for good reason, alongside existing options for 20,000,000 common shares at $0.10. These actions are already approved and will become effective at least 20 days after the information statement is mailed and required Nevada filings are accepted; no stockholder meeting, vote, or dissenters’ rights are provided.
Eva Live Inc., through its wholly owned subsidiary Eva Defense Inc., has entered into a development agreement with Boumarang Inc. to create a resilient communications unmanned aircraft system. Eva Defense will fund a twelve‑month engineering program in which Boumarang will design, build, and test the platform.
The company has committed $1.2 million, payable at $100,000 per month from August 5, 2026 through July 31, 2027. The program is structured around milestone “gates” — feasibility, proof of concept, field test, and beta — with Eva Defense approval required to advance. Target outputs include 10 to 20 field‑tested, beta‑ready prototypes, a low‑rate initial production plan, and an NDAA‑compliant supplier base. Deliverables transfer to Eva Defense upon full payment, while Boumarang’s background technology is licensed on a non‑exclusive basis. The initiative is at an early stage with no customer, contract award, or program of record, and Eva Live has not yet generated defense revenue.
Eva Live Inc. reported total revenue of $4,204,390 for the quarter ended June 30, 2026 and $8,107,621 for the first six months, compared with $4,138,712 and $7,820,232 in the prior-year periods. The company recorded a net loss of $1,749,757 for the quarter and $10,313,833 year-to-date, versus net income of $2,625,101 and $4,620,795 a year earlier, as operating expenses rose substantially, including higher media traffic costs and large non-cash stock-based and financing charges.
Cash used in operating activities was $5,229,216 in the first half of 2026, while cash and equivalents were $2,238,216 at June 30, 2026, funded largely by $7,576,760 of financing inflows, including a $7,560,000 senior secured convertible note from Streeterville Capital and at-the-market equity sales. Net accounts receivable were $17,465,015, about 88% aged more than 90 days and concentrated in a small number of customers, and the company also held $1,209,005 of marketable securities and a $3,000,000 equity interest in Psquared Inc.
Management cites these factors, together with media traffic purchase costs equal to 84% of six-month revenue and potential cash redemptions under the Streeterville note, in concluding that substantial doubt exists about the company’s ability to continue as a going concern over the next year, despite reported working capital of $19,439,564 and stockholders’ equity of $17,103,978.
Eva Live Inc. entered into a securities purchase agreement with Streeterville Capital, LLC for a secured convertible note with $2,160,000 original principal, from which the company will receive $2.0 million of gross proceeds at Closing. The note carries an 8% original issue discount, 8% annual interest, and a 24‑month maturity, with proceeds earmarked for working capital, general corporate purposes and advancement of business objectives.
The note is convertible at the investor’s option into common shares at 87% of the lowest daily VWAP over 10 trading days, subject to a $0.472 floor price. Eva Live may prepay with 10 trading days’ notice by paying 110% of the prepaid outstanding balance. If the share price remains below the floor for 10 consecutive trading days, the investor can redeem up to a contractually defined monthly amount, and specified Major or Minor Trigger Events can increase the outstanding balance by 10% or 5% per occurrence, within stated caps, with uncured events escalating to an Event of Default that bears 15% default interest.
The note is secured under a security agreement granting a lien over collateral including equity interests in all subsidiaries, customer accounts, insurance‑related rights, and goods and equipment. Conversion shares are registered on Eva Live’s Form S‑3 shelf registration statement, supported by a July 2026 prospectus supplement.